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Microbial natural products are some of the most im-
portant pharmaceutical agents and possess unparal-
leled chemical diversity. Here we present an untar-
geted metabolomics algorithm that builds on our
validated iSNAP platform to rapidly identify families
of peptide natural products. By utilizing known or
in silico-dereplicated seed structures, this algorithm
screens tandem mass spectrometry data to elabo-
rate extensive molecular families within crude micro-
bial culture extracts with high confidence and statis-
tical significance. Analysis of peptide natural product
producers revealed an abundance of unreported
congeners, revealing one of the largest families of
natural products described to date, as well as a novel
variant with greater potency. These findings demon-
strate the effectiveness of the iSNAP platform as an
accurate tool for rapidly profiling large families of
nonribosomal peptides.
INTRODUCTION
Small-molecule natural products have long served as a valu-
able source of pharmaceuticals, providing molecular scaffolds
useful in treating an ever-expanding range of pathologies. Mi-
crobial natural products, particularly the polyketides and nonri-
bosomal peptides, have proved particularly useful as a source
of antibacterial drugs and scaffolds, making up roughly two-
thirds of clinical antibacterials since 1981 (Newman and Cragg,
2007). Polyketides and nonribosomal peptides are produced
by modular assembly line-like enzymes (PKSs and NRPSs)
that frequently display promiscuity in substrate selection and
chemical tailoring reactions, giving rise to molecular families
based on a set scaffold. By utilizing this promiscuity, a single
assembly line can deploy a library of molecules that can
possess divergent affinities for a given target, or even different
activities (Yu et al., 2012). As the forces that drive the evolution
of these molecules in the environment are typically not directed
toward clinical needs, minor analogs can often be identified
with substantially improved clinical utility, including drugs andChemistry & Biology 22, 1259–126leads such as mannopeptimycin (He et al., 2002), rhizoxin
(Scherlach et al., 2006), epothilone (Chou et al., 1998), pneu-
mocandin (Balkovec et al., 2014), and burkholdine (Lin et al.,
2012). Similarly, minor differences in homologous assembly
lines (observable in sequenced genomes and metagenomes)
can produce related natural products with superior activity
(Wang et al., 2011). In each instance, variations in substrate-
or monomer-selection promiscuity by NRPS/PKS enzymes
can lead to the generation of natural biosynthetic libraries
with a range of target affinities and biological effects. Tradition-
ally, natural product discovery efforts have led to the most
abundant members being targeted through bioassay-guided
fractionation, as bioactivity is concentration dependent. Such
limited sampling can lead to an underestimation of a scaffold’s
potential as a therapeutic agent, as superior minor variants
may go undiscovered. Reanalysis and reengagement of over-
looked natural product scaffolds will likely facilitate the dis-
covery of analogs with improved pharmaceutical properties,
providing new clinically useful structures and scaffolds for
further development.
Traditional natural products chemistry approaches based on
bioactivity-guided isolation and rigorous structure elucidation
techniques have provided the vast majority of pharmaceutically
relevant natural products. Unfortunately, these techniques are
biased toward abundant compounds and necessitate large
amounts of material, expertise, and time, often requiring months
of work for the identification, isolation, and elucidation of a single
natural product. Reanalyzing microbial culture extracts for over-
looked molecules will require techniques that can provide sys-
tems-level analysis and define both structures and retention
times to prioritize and facilitate subsequent isolation efforts.
This requirement is complicated by the diversity of natural
product families, whose exotic molecular scaffolds confound
the development of automated analyses, and whose frequent
isobaric species prevent accurate and automated structure
elucidation. While genome sequencing data can provide predic-
tive value in guiding discovery efforts (Kersten et al., 2011), ob-
taining sufficiently well-assembled biosynthetic gene clusters
for accurate structure predictions can be time consuming,
impeding discovery and development efforts. Pure, untargeted
metabolomic approaches that make use of liquid chromatog-
raphy-coupled mass spectrometry (LC-MS) remain a powerful
means of rapidly assessing chemical potential (Winnikoff et al.,
2014; Yang et al., 2013; Hou et al., 2012), and are uniquely9, September 17, 2015 ª2015 Elsevier Ltd All rights reserved 1259
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Figure 1. iSNAP Analog Discovery Algorithm Can Map Families of Natural Peptides
(A) Schematic workflow of the automated iSNAP analog algorithm. After uploading an LC-MS/MS data file (.mzXML), users are required to define seed structures
of interest—either predefined or following initial iSNAP dereplication analysis—in addition to a mass window around these seeds. Following dereplication, the
algorithm searches the defined mass window and generates candidate analog structures. Hypothetical candidates are fragmented in silico to facilitate MS/MS
fragment matching and monomer localization, driving the automated identification of structural analogs from the initial seed.
(B) Amino acid composition of tyrocidine A (tyrocidine 16; black) and various substitutions found in the remaining 27 known members of the tyrocidine family of
cyclic peptide natural products (gray).
(C) Tyrocidine single-monomer substitution networks. Structures of tyrocidines 1–28 dereplicated by iSNAP (red) or known from previous literature (gray) are
connected to one another through single amino acid substitutions (left). Through iSNAP analog analysis, single seeds can be used to access related structures,
demonstrated using tyrocidine A (right).positioned to facilitate high-throughput, information-rich anal-
ysis of complicated microbial extract libraries with high sensi-
tivity. Mirroring advances in LC-MS-based proteomics, a num-
ber of targeted metabolomic approaches have been explored
for the detection of peptide natural products (Kersten et al.,
2011; Mohimani et al., 2011, 2014a, 2014b), which reliably frag-
ment along amide bonds but frequently possess complicated
architectures. Following pioneering work in 2009 defining a de
novo means of sequencing cyclic peptides (Ng et al., 2009), a
number of approaches with varying degrees of automation
have worked toward rapid, accurate detection of complex pep-
tide sequences, first from standards (Mohimani et al., 2011)
and then from microbial culture extracts (Kersten et al., 2011;
Mohimani et al., 2014a, 2014b). In 2012 we defined iSNAP, a
novel algorithm capable of detecting known peptide natural
products from complex culture extracts (Ibrahim et al., 2012).
Taking advantage of a comprehensive in-house database of
known peptide natural product structures, this automated ‘‘der-
eplication’’ technology screens LC-coupled tandem MS (MS/
MS) data and applies a series of statistical processes to identify
known compounds based on matching peaks between real and
in silico MS/MS fragments. Here, we present a new analog mod-
ule for the iSNAP platform (available at http://magarveylab.ca/
analog/), facilitating both dereplication and highly accurate
analog identification, which is capable of discerning between1260 Chemistry & Biology 22, 1259–1269, September 17, 2015 ª201isobaric species and automatically providing structures for
novel, superior analogs from nanograms of material.
RESULTS
iSNAP Analog Search Algorithm
iSNAP analog search is an algorithm designed for the discovery
of novel analogs of known peptide natural products from tandem
mass spectral data. It is built on the iSNAP platform to extend the
platform’s capability of elucidating families of peptide natural
products. As it is known that families of peptide natural products
can co-exist in microbial culture extracts, the dereplication of a
peptide is often a good indication of the existence of analogs
that have similar structures. In line with this observation, the
algorithm is designed to utilize dereplicated peptides as seed
structures to guide the search for analogs with similar structures.
The analog search algorithm takes tandemmass spectral data
and a list of seed structures as inputs. It analyzes each tandem
mass spectrum individually in the following steps: (1) construct
analog candidates that are one monomer different from seed
structures; (2) match the spectrum to hypothetical spectra of
analog candidates; (3) evaluate the matches by calculating p-
value-derived scores, P1 and P2; (4) report the identified analog,
if the best match has scores above specified thresholds (Figures
1A and S1). The algorithm reports the seed structure, the5 Elsevier Ltd All rights reserved
monomer site of difference, and the mass difference for each
identified analog.
Construction of Analog Candidates
Assuming the parent mass of a tandemmass spectrum isM and
themass values of seed S1, S2,., Sn arem(S1),m(S2),.,m(Sn),
the algorithm first compares M with the mass of each seed. A
seed is selected to generate analog candidates if themass differ-
ence is smaller than a user-specified threshold MT. We denote
the selected seeds as S^1, S^2,., S^m, and we have
S^˛

Si
jMmðSiÞj<MT

; where i = 1;.n:
For each selected seed S^, the algorithm annotates amide
bonds and ester bonds in its structure. Monomer blocks be-
tween two adjacent bonds are therefore detected and numbered
as R1, R2,., Rr. The algorithm assumes that the true structure
for the spectrum is an analog that can be constructed from the
seed by modifying one monomer. The modified monomer ac-
counts for the mass difference between the seed and the spec-
trum parent mass. As such, analog candidates are generated by
adding the mass difference to each and every monomer block in
the seed.
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For each generated analog candidate, there is one monomer
Ri with altered mass value to make up for the mass difference
MD. This ensures the mass of every analog candidate matches
with the spectrum parent mass M. The process only involves
mass calculation, and the program does not attempt to make
structural interpretation for the modified monomer, as this is
challenging to decipher using MS/MS alone. Therefore the pro-
gram does not need a monomer database, such as Norine, for
generating analogs, providing an unbiased method for identi-
fying substitutions and monomers.
Evaluation of Analog Candidates
Having generated analog candidates from selected input seeds,
a scoring mechanism is needed to evaluate the significance of
matching between a spectrum and an analog candidate. In this
work, we adopted the scoring system validated in the original
iSNAP database search algorithm. A match between a spectrum
and analog candidate is evaluated with three scoring metrics:
raw score, P1 score, and P2 score.
Raw score is a basic spectral-matching score. The algorithm
generates hypothetical spectral fragments of the analog can-
didate using the original iSNAP platform. The mass-to-charge
ratios of these hypothetical fragments are matched to the spec-
trum. The raw score is then calculated as the logarithmic sum of
the peak intensity of all the matched peaks.
P1 score is a statistical normalization of the raw score. By
scoring the spectrum with all compounds in the dereplication
database, we acquire a raw score distribution of random
matches. For an analog candidate, a p value is calculated by
its raw score on this distribution. As P1 score is subjected toChemistry & Biology 22, 1259–126the composition of the database, having similar structures in a
database would slightly skew the distribution and affect the
p value. A P2 score was introduced to alleviate this issue. By
shifting all peaks in the spectrum, a list of false spectra is created
to match with the compound, generating a distribution for
p-value calculation. The calculation of P2 score is independent
of other database structures. Both P1 and P2 score are con-
verted from p values for better readability using the formula
P1 = 10log10(p value). A higher P1 score indicates lower prob-
ability to have a random structure matching better with the spec-
trum. A higher P2 score indicates lower probability to have a
random spectrum matching better with the analog candidate.
For each spectrum, P1 score and P2 score are calculated for
every analog candidate. Analog candidates are deemed signifi-
cant if having both P1 score and P2 score higher than the spec-
ified thresholds. By default, the thresholds for P1 and P2 are set
to 27 and 24, respectively, as empirically determined in our pre-
vious work. The thresholds can be adjusted by the user to give
more flexibility in result filtering.
Elaborating the Tyrocidine Family
To test whether this new algorithm would be capable of accurate
analog detection, we chose to analyze crude extracts of Bacillus
parabrevis, which produces the tyrocidines, one of the most
diverse and well-annotated natural product complexes known.
The tyrocidine family of cyclic decapeptides comprises 28
known structural variants (Tang et al., 1992) made up of amino
acid substitutions within the peptide core (Figure 1B), with rela-
tive abundances ranging from 1% to 100%. An examination
of the chemical space of the tyrocidines (Figure 1C) reveals the
single-monomer interconnectivities or ‘‘network’’ of the tyroci-
dine scaffold, highlighting the correlations between the struc-
tures in terms of monomer position and mass difference. As a
first step, we optimized our LC conditions with a focus on the
use of high-efficiency core-shell columns. This proved useful in
resolving many of the co-eluting peaks, allowed for greater con-
fidence of low-abundance compounds, and avoided excess arti-
fact hits within the ion trap (Figure S2). Following established
fermentation and extraction conditions (Tang et al., 1992), LC-
MS/MS analysis was performed followed by automated metab-
olite dereplication by iSNAP, to validate the number of tyrocidine
compounds within the crude extract. Over a 37-min interval,
iSNAP dereplicated 21 of the 28 reported structures (Figure 1C
and Table S1). While several of the low-abundance tyrocidines
were not detected, this is likely a result of minor discrepancies
in culture conditions affecting metabolite production or analytes
being below the intensity threshold of the automated MS/
MS settings, as manual investigation also failed to reveal the
missing, previously reported structures. Having identified 21 ty-
rocidines within the fermentation culture, we used these derepli-
cated spectra as references for evaluating analog identification
and testing the monomer localizations within the tyrocidine sin-
gle-monomer substitution network (Figure 1C). The LC-MS/MS
data file was rescreened 21 times with the iSNAP analog search
algorithm, using each dereplicated structure as the seed. For
each seed structure processed, only the analog identifications
corresponding to the reference spectra are evaluated. By com-
paring the analog identifications with the dereplicated struc-
tures, we can determine whether a correct identification is9, September 17, 2015 ª2015 Elsevier Ltd All rights reserved 1261
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Figure 2. Analog Identification and Localization
(A) In silico candidate analog screening with predefined monomer substitutions. To evaluate analog identification and correct monomer localization rates, hy-
pothetical seeds of cyclic peptides were substituted with glycine, alanine, threonine, histidine, or 5-Br-tryptophan at each position and used to identify their
corresponding standard within LC-MS/MS data. Positively identified analog candidates with correct localization are shown in cyan, analog candidates with
incorrect localization are shown in red, and non-matching seed structures (unidentified) are shown in black.
(B) Analog identification and localization rates from in silico candidate screening of 17 dereplicated tyrocidines. A total of 17 tyrocidine compounds have been
evaluated, representing candidates with relative abundances of 1%–100%. A total of 170 candidate seed structures are evaluated for each substituted
monomer, representing a total of 850 analog screens. The analog hit rate represents the total number of analog seed structures correctly matched to an MS/MS
spectrum (localized and mislocalized), scored above the P1 and P2 cutoffs, and divided by the total number of matches possible. The localization rate is the total
number of positive localizations divided by the total number of analog matches.made. As we had expected, the iSNAP analog program correctly
matched each MS/MS spectra with its corresponding analog
seed structure (Figures 1C and S3). As an example, using tyroci-
dine A (TC#16) as the seed, the analog search made correct
identifications on the MS/MS spectra of tyrocidines #10, 12,
17, 18, and 19, with mass differences and localization correctly
identified; +39 m/z at monomer 7, +39 m/z at monomer 6, +14
m/z at monomer 2, +23 m/z at monomer 10, and 16 m/z at
monomer 10, respectively. By making use of MS/MS data, the
iSNAP analog programwas capable of reliably distinguishing be-
tween isobaric analogs: (1) TC #10 and 12, difference in one site
modification Phe6-Trp7 and Tryp6-Phe7, respectively; (2) TC #18
(Phe6-Phe7,Trp10) and TC-24 (Trp6-Phe7,Phe10). These reliably
accessed networks suggest that through iterative dereplication
and analog steps, it is possible to access all known tyrocidines
following the dereplication of a single structure (Figures 1C and
S3). These examples demonstrate the utility of the iSNAP analog
program, having elaborated the tyrocidine family of cyclic pep-
tides and correctly localized sites of variation within the scaffold.
In Silico Investigation of Analog Identification and
Localization Rate
We next sought to establish a controlled testing scenario in
which we could evaluate, with confidence, the effectiveness of
iSNAP’s ability in making sensitive analog identifications, and
determine the accuracy with which the algorithm can localize
structural differences. More specifically, the analog identification
and localizations rates can provide a performance indicator or a
measure of how the algorithm may perform when evaluating LC-
MS/MS datasets in a real analog searching scenario.
In this experiment, we evaluate LC-MS/MS and MS/MS data-
sets using the iSNAP analog search algorithm to first search and
dereplicate any known NRPS structures. We then artificially
create, in silico, new analog seed structures of the dereplicated
knowns, by making alterations to the NRPS scaffold, one mono-1262 Chemistry & Biology 22, 1259–1269, September 17, 2015 ª201mer site at a time. In this testing scenario, the iSNAP analog
search algorithm should be capable of correctly identifying all
of the artificial in silico seed structures as being analogous to
the known NRPSs. Moreover, it should be capable of accurately
localizing the position of the altered sites within the NRPS scaf-
fold. By evaluating a series of NRPS structures from crude mi-
crobial extracts we can realize, with high confidence, iSNAP’s
potential as being a sensitive and accurate discovery tool within
this controlled setting.
For this experiment, we first manually created a series of
in silico seed structures for 17 of the dereplicated tyrocidines
by substituting a new monomer block at each of the ten residue
positions. The selected tyrocidines represent those with low and
high abundance (Figures 2, S4, and S5), avoiding any bias to-
ward those with higher-quality MS/MS spectra. We next incor-
porated a range of monomers that are not present within the
tyrocidine family scaffold. As the tyrocidine family scaffold com-
prises only 12 amino acid building blocks (Figure 1B), we
selected five different amino acids as in silico substitutions for
the artificial seed structures, representing increasing mass-to-
charge values: glycine, alanine, threonine, histidine, and a 5-
Br-tryptophan. We selected the new monomers to avoid any
bias toward common fragmentation losses or conserved se-
quences as well as any bias associated with small or large
mass differences that might be more readily matched within
the MS/MS spectra of tyrocidines.
For the 17 dereplicated tyrocidines, these newly created and
artificial seed structures represent a total of 850 in silico variants
being evaluated, with 50 per structure (10 positions3 5 substitu-
tions), and 170 variants globally per substitution (Figures 2, S4,
and S5; Table S3). Using the constructed seed structures,
we can then use the iSNAP analog search algorithm and examine
the analog identifications made to the dereplicated tyrocidine
spectra. From these results, analog identification rates and
monomer localization rates can be established, providing a5 Elsevier Ltd All rights reserved
diagnostic for the algorithm’s performance. The analog identifi-
cation rate for the in silico variants is calculated by the total num-
ber of analog seed structures correctly matched to an MS/MS
spectrum (localized and mislocalized), scored above the P1
and P2 cutoffs, and divided by the total number of matches
possible. The monomer localization rate is calculated as the total
number of positive localizations divided by the total number of
analog matches. As we expected, variations in the analog iden-
tification rate could be seen across the substituted amino acids,
resulting in a global analog identification rate of 79.41% (675/
850) for the tyrocidine family (Figures 2 and S5; Tables S2 and
S3). On an individual basis, the analog identification rates are
87.65%, 90.00%, 67.65%, 61.18%, and 90.59% for glycine,
alanine, threonine, histidine, and 5-Br-tryptophan, respectively.
Rewardingly, of the analogs identified the global monomer local-
ization rate is more than 88% (595/675), with rates of 83.22%,
92.81%, 93.04%, 90.38%, and 83.12%, for glycine, alanine,
threonine, histidine, and 5-Br-tryptophan, respectively. To ex-
pand on these initial findings, we further probed the molecular
scaffolds of several other cyclic peptides (WS9326a, seglitide,
surfactin B) to evaluate analog identification rates and monomer
localization rates, using the five substituted monomers as
in silico seeds. In the case of WS9326a, seglitide, and surfactin,
analog identification rates were 73%, 87%, and 98%, with
monomer localization rates of 59%, 100%, and 87%, res-
pectively (Figures 2 and S5). These findings demonstrate the
effectiveness of the iSNAP analog algorithm in identifying
analog variants and localizing structural differences with high
accuracy.
Iterative Analog Analysis Maps the Loloatins, Rare
Tyrocidine-like Cyclic Peptides
Building on our tyrocidine network findings, we sought to identify
small-molecule products of a tyrocidine-like NRPS in the ge-
nome of the previously uninvestigated isolate Brevibacillus later-
osporus (DSM 25). B. laterosporus was cultured, extracted, and
subjected to LC-MS/MS analysis, providing an.mzXML data
file that could be analyzed by the iSNAP algorithm to identify
peptide natural products. Rather than the well-studied tyroci-
dines, iSNAP LC-MS/MS analysis revealed the loloatin-related
natural products, which possess two constitutive substitutions
that differentiate them from the tyrocidines (Gerard et al.,
1999). These peptides possess considerably improved activity
relative to the tyrocidines, against multidrug-resistant Gram-
positive and Gram-negative bacteria (Gerard et al., 1999). In
contrast to the well-studied tyrocidines, only four loloatin struc-
tures have been previously reported, and of these we only
observed production of loloatin A. To identify novel variants,
we screened the culture extract using the four known structures
(loloatins A–D) as seeds for iterative analog profiling. Following
each round of analysis, analog identifications were confirmed
by manual MS/MS examination and annotation (Appendix 1),
with correctly identified analogs forwarded as seeds for the
next round of discovery. After four rounds of iterative iSNAP
analog search, we identified a total of 33 new loloatins (Figure 3),
including 22 which have been identified as unique structures,
along with nine structures which are presumably isomeric ana-
logs, and two structures that could not be confirmed by manual
MS/MS annotation due to poor-quality MS/MS spectra. Of theseChemistry & Biology 22, 1259–12633 identified loloatins, 25 demonstrated correct monomer local-
izations (Appendix 1). Only threeMS/MS scanswere detected as
false positives throughout the analysis, and with low P scores
(average FP P1/P2 of 24.5/23.4; global P1/P2 of 61.4/30.1). By
iterating our analog approach, we successfully identified an
entire family of loloatins comprising 22 distinct, novel variants,
revealing an extensive network similar to that of the tyrocidine
family.
Automated Analoging Reveals a Massive Family of
Lipodepsipeptides
Next, we chose to examine a more modified peptide architec-
ture, one incorporating acyl and ester moieties. We focused
our efforts on the LI-F0 series of lipodepsipeptides from Paeni-
bacillus polymyxa. Originally described in 1987 (Kurusu et al.,
1987), these nonribosomal hexapeptides possess a rare gua-
nidinylated acyl tail, and demonstrate considerable variability
in the incorporation of hydrophobic amino acids (Val/Ile and
Val/Ile/Phe/Tyr) at positions 2 and 3. These substitutions, along
with variable Asn/Gln incorporation at position 5, have led to
the elucidation of 12 reported structures, although 16 distinct
molecules are theoretically possible with modifications at
these sites. These structures have not yet been discovered
through earlier MS/MS works (Kuroda et al., 2001) or synthetic
biology efforts (Han et al., 2012), likely a result of their low abun-
dance. To assess whether the iSNAP analog search algorithm
could display sufficient sensitivity to identify these proposed
analogs and reveal any unforeseen variants, we cultured 6 l of
P. polymyxa and extracted the supernatant for iSNAP analysis.
As we had expected, each of the 12 known LI-F0 structures
was reliably dereplicated, with retention times relatively similar
to those in published works (Kurusu et al., 1987) and MS/MS
fragmentation patterns consistent with the LI-F0 scaffold (Fig-
ure 4, Appendix 2). Surprisingly, the iSNAP analog search also
revealed the presence of an entire suite of unreported LI-F0 var-
iants (Figure 4). iSNAP analysis of the P. polymyxa crude extract
revealed 39 novel variants, detected over 42.4 min (Figure 4),
making this, to our knowledge, the largest natural product com-
plex ever discovered from a single organism, with more than 50
structures identified (Figure 4; Appendix 2). During the analysis
no other secondary metabolites were detected, while 10 of
4,339 scans (average FP P1/P2 of 24.8/23.4; global P1/P2 of
29.0/36.5) were false positives and attributed to artifacts, as re-
vealed by manual inspection (Appendix 2). Furthermore, seven
compounds were correctly identified as LI-F0 antibiotics by
iSNAP but were incorrectly annotated due to convoluted frag-
mentation or insufficient abundance; three were assigned by
manual MS/MS annotation. This complex series of structures
appears to arise from several recurring variations, including
amino acid substitutions at every position (such as Ser/Thr1,
Val/Ile/Leu2, Val/Ile/Leu/Phe/Tyr3, Ser/Thr4, Asn/Gln/Glu5, Ala/
Gly6), linearization of the macrocycle ester, loss of the terminal
alanine, or addition of a second C-terminal monomer (Ala or
Gly). The four analogs that complete the original set arising
from combinatorialization of monomers at positions 2, 3, and
5 were also observed, with preliminary quantification efforts
demonstrating an isolatable yield of 1 mg/l. The obscurity of
these variants is evident in both the LC-MS/MS chromato-
gram and the corresponding LI-F0 family network (Figure 4C),9, September 17, 2015 ª2015 Elsevier Ltd All rights reserved 1263
0 10 20 30 40 50 Time [min]
B
C
20 22 24 26 28 30 32 Time [min]
1312 Da
1262 Da1291 Da
1245 Da 1259 Da
1181 Da 1257 Da
1271 Da 1273 Da
1287 Da 1223 Da
1237 Da
1274 Da
1238 Da
1207 Da
1316 Da
1221 Da
1258 Da
1242 Da
1224 Da
1208 Da
1281 Da
1222 Da
A
Iterative
Analogue
Profiling
Loloatin F
O
NH
H2N
O
H
N
HN
NH
N OH
HN
N
H
NH2
H
N
HN
HO
HN O
O
O
O
O
O
O
O
O
O
HO
O
H2N
H
N
O
HN
O
NH
O
NO
HN
O
N
H
O
H
NO
HN
O
HN O
NH
O
O
HO
OH
NH2
O
H2N
H
N
O
HN
O
NH
O
NO
HN
O
N
H
O
H
NO
HN
O
HN O
NH
O
O
HO
OH
NH2
Loloatin U Loloatin L
Figure 3. Iterative Informatic Exploration of Loloatin Chemical Space
(A) Informatic detection of a large family of loloatin natural products from a crude extract of B. laterosporus (DSM 25). Red arrowheads denote unique loloatins
identified by iSNAP. Black arrowheads denote natural products that were falsely identified.
(B) Extracted ion chromatograms of loloatin natural products. EachMS/MS scan determined by iSNAP to contain new loloatin structures is colored red, whileMS/
MS scans containing known loloatins are colored cyan.
(C) Expansion of known loloatin chemical space through four rounds of iterative iSNAP analog identification. Loloatin species are represented as nodes sized by
abundance and connected by single-monomer substitutions. Known loloatins identified in this work are shown in cyan, while new loloatins identified in this work
are shown in red. Previously discovered loloatins that were not observed in this work are shown in gray. The magnified section of the analog network depicts
structural alterations linking three new loloatins.thus underscoring the analytical and discovery value of infor-
matic search approaches in revealing previously undiscovered
structures.
Identification and Elucidation of a Minor Arylomycin
Variant with Improved Bioactivity
Following our lipodepsipeptide screening, we next chose to
investigate glycosylated natural products for new,minor variants
that may yield superior bioactivity. We analyzed a series of ex-
tracts from environmental Actinomycetes to identify candidate
natural products, and detected a suite of glycosylated arylomy-
cins (Figure 5A), which had previously been reported by re-
searchers at Eli Lily as potent inhibitors of type 1 signal peptidase
with antibacterial and b-lactam-sensitizing activity (Kulanthaivel
et al., 2004). iSNAP analog analysis of these partially cyclic, gly-
cosylated lipopeptides identified a total of six novel variants, with
alterations in acyl tail length and phenylglycine dihydroxylation.
With these new findings, we then reinvestigated our crude ex-
tracts for additional analogs using the novel structures as seeds.
Prior to running the iSNAP analog search algorithm, we first der-
eplicated the novel structures to further validate and confirm the
annotations. Next, we expanded the analog mass tolerance win-
dow to facilitate the discovery of more divergent analogs. During
this second round of study, the iSNAP analog search identified1264 Chemistry & Biology 22, 1259–1269, September 17, 2015 ª201an additional four congeners, corresponding to aglycones of
the original series (Schimana et al., 2002), which could be
confirmed by multistage mass spectrometry (MSn) analysis (Fig-
ure 5; Appendix 3). Previous SAR studies on this antibacterial
complex identified that decreasing acyl tail lengths led to
increased activity against Gram-negative bacteria such as Es-
cherichia coli (Kulanthaivel et al., 2004). To assess whether the
shorter acyl tails observed in our novel minor variants led to
improved activity, we isolated one of these structures (molecular
weight [MW] 1,000 Da; isolated at17 mg/l) for bioactivity testing
and structure elucidation alongside the previously described
parent structure (MW 1,014 Da; isolated at 220 mg/l). High-res-
olution mass spectrometry (HRMS) measurement of the novel
variant matched our expectation as glycosylated arylomycin,
having a shorter acyl tail ([M + H]+: C49H73N6O16; 1.198 ppm
error; Appendix 4). However, comparison of the 1H, 13C-hetero-
nuclear multiple-bond correlation, 1H, 1H-correlation spectros-
copy, and 1H, 1H-total correlation spectroscopy experiments
between the 1,014-Da parent and the 1,000-Da analog revealed
differences in the N-methylated N-terminal amino acid, which is
not readily seen within the MS/MS spectra. In contrast to the N-
methyl serine observed in the parent structure, the minor novel
variant possesses both an N-methylated threonine and shorter
acyl tail (C12 versus C14). With the exception of the chemical5 Elsevier Ltd All rights reserved
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Figure 4. iSNAP-Driven Discovery of a Massive Family of LI-F0 Series Natural Products
(A) Informatic detection of a massive family of LI-F0 series lipodepsipeptides from a crude extract of P. polymyxa (ATCC no. 21,830). Red arrowheads denote
unique LI-F0 series products identified by iSNAP. Black arrowheads denote natural products that were falsely identified.
(B) Extracted ion chromatograms of LI-F0 series molecules. Each MS/MS scan determined by iSNAP to contain new LI-F0 series structures is colored red, while
MS/MS scans containing known LI-F0 series molecules are colored cyan. Scans containing molecules incorrectly identified as LI-F0 series compounds are
shown in gray.
(C) Expansion of known LI-F0 series chemical space through iSNAP analog identification. LI-F0 species are represented as nodes sized by abundance and
connected by single-monomer substitutions. Known LI-F0 series molecules identified in this work are shown in cyan, while new LI-F0 series molecules identified
in this work are shown in red. The magnified section of the analog network depicts structural alterations linking two new LI-F0 series structures.shifts associated with the substituted amino acid, our findings
are consistent with the fully resolved and elucidated parent
structure (Appendix 4). To assess whether this minor variant
possessed superior activity to the more abundant parent com-
pound, we selected a sensitive E. coli test strain, similar to that
used originally by researchers at Eli Lily (Kulanthaivel et al.,
2004). Microdilution minimum inhibitory concentration (MIC) as-
says of our novel arylomycin variants against E. coli revealed
that, consistent with previous findings (Kulanthaivel et al.,
2004), our short-tail variant possessed modestly greater activity
compared with the parent compound, withMIC values of 0.6 and
0.4 mg/ml, respectively.
DISCUSSION
During the golden age of natural product antibiotic discovery,
researchers identified a staggering number of unique chemical
scaffolds, including several that have endured as modern
therapeutic agents (Newman and Cragg, 2007). However, the
vast majority of these bioactive molecules were discarded,
as apparent chemical diversity provided more efficacious or
easily developed leads, such as glycopeptides and macrolide
antibiotics. Daptomycin (originally LY 146032) was one such
discarded scaffold that went through years of genomic and me-
tabolomic engineering to emerge as an immeasurably useful
antibiotic (Eisenstein et al., 2010). As resistance to conventionalChemistry & Biology 22, 1259–126antibiotic scaffolds continues to rise, reinvestigation of over-
looked natural products may prove to be a valuable method for
meeting clinical demand.
Microbial natural products are thought to be exceptionally
bioactive because they possess evolved chemical scaffolds
that provide fitness benefits to the producer organism within
their native environment. While these evolved molecules provide
excellent leads for drug development, properties that are useful
in a natural environment are often at odds with our desires for
their use as pharmaceutical agents. Given this disparity, there
is not necessarily a direct correlation between the abundance
of a given congener and its activity toward a pathogen of interest
(He et al., 2002; Balkovec et al., 2014; Lin et al., 2012; Gerard
et al., 1999; Kurusu et al., 1987). Given the intrinsic promiscuity
of many biosynthetic enzymes and the resultant chemical diver-
sity observed in natural product extracts, metabolomic investi-
gations of undeveloped scaffolds can lead to the discovery of
new variants with improved pharmaceutical potential. Fast and
reliable automatedmethods are now sorely needed tomine large
extract libraries and expand the chemical space of clinically
promising pharmacophores.
LC-MS/MS is currently the benchmark standard for rapidly
profiling complex natural product extracts, and MS/MS can be
used to mine vast quantities of rich data to identify chemical en-
tities. During the past decade a number of methodologies have
been developed that make use of de novo MS/MS sequencing9, September 17, 2015 ª2015 Elsevier Ltd All rights reserved 1265
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Figure 5. Expansion of Glycosylated Arylomycin Chemical Space Facilitates the Discovery of an Analog with Improved Bioactivity
(A) Informatic detection of a family of arylomycin natural products from a crude extract of environmental Actinomycete isolate NAM12. Red arrowheads denote
unique arylomycins identified by iSNAP. Black arrowheads denote natural products that were falsely identified.
(B) Extracted ion chromatograms of arylomycins. MS/MS scans determined by iSNAP to contain new arylomycin structures based on the dereplicated glyco-
sylated arylomycin scaffold are shown in red, and scans containing known glycosylated arylomycins are shown in cyan. A new analog (1001 Da [M +H]; inset) was
isolated and its structure elucidated by HRMS, 1D NMR, and 2D NMR experiments.
(C) Expansion of known arylomycin chemical space through two rounds of iterative iSNAP analog identification. Arylomycin species are represented as nodes
sized by abundance and connected by single-monomer substitutions. Known glycosylated arylomycins identified in this work are shown in cyan, while previously
unobserved glycosylated arylomycins and corresponding aglycones identified in this work are shown in red. Previously discovered glycosylated arylomycins that
were not observed in this work are shown in gray. The new, more active arylomycin variant is denoted with a star. The magnified section of the analog network
depicts structural alterations linking two arylomycin aglycones.techniques (Ng et al., 2009; Medema et al., 2014) and genomic
data (Kersten et al., 2011; Mohimani et al., 2014a, 2014b), in ef-
forts to guide the discovery of ribosomal and nonribosomal pep-
tides. In the case of iSNAP, by making use of a comprehensive
library of peptide natural product structures, we can utilize our
validated statistical algorithms (Ibrahim et al., 2012) to expand
the known chemical space of key natural products identified in
an untargeted and automated manner. Because the iSNAP
analog program is supplied as a user-friendly Web application,
it provides a more straightforward and directed means of identi-
fying the structures and locations of families of peptide natural
products using LC-MS/MS data from crude microbial extracts.
This pure metabolomics approach capitalizes on the extensive
knowledge base of natural product chemistry and is not neces-
sarily tied to genomic data, which is not always available for
extant microbial extract libraries.
We have demonstrated that the iSNAP analog function can
provide consistent and accurate results using low-resolution
LC-MS/MS data of crude extracts containing low concentrations
of natural products. This is in contrast to previously published de
novo sequencing approaches that required pure, cyclic peptide
standards that were directly infused for high-resolution MSn
analysis (Ng et al., 2009). While de novo sequencing represented
a pioneering achievement compared with earlier works, the chal-
lenges of this technique remain, including issues with mixtures of
‘‘direct sequence ions’’ and ‘‘nondirect sequence ions’’ in cyclic1266 Chemistry & Biology 22, 1259–1269, September 17, 2015 ª201peptides, where multiple ring-opening events can occur and
complicate sequencing. While early programs could be de-
signed for analysis of pure standards of cyclic peptides (Ng
et al., 2009; Mohimani et al., 2011), they were not applicable to
complex mixtures containing other architectures of nonriboso-
mal peptides. In addition, while foundational early work demon-
strated effective use of informatic search strategies to correctly
identify structures from large databases (Mohimani et al.,
2011), peptide standardswere typically pretreatedwith chemical
reducing agents to increase fragmentation, an approach that
is not amenable to metabolomics studies of natural product
extracts.
One important application of the iSNAP analog algorithm is
the rapid analysis of peptide natural product mixtures and
the identification of related molecular families. Visualization of
natural product families can also be performed using molecular
networking approaches (Watrous et al., 2012; Nguyen et al.,
2013) that cluster observed ions, based on similarities in their
mass spectral fragmentation patterns. Fragment commonalities
are scored using cosine vectors (Frank et al., 2008) that ease
the clustering of related spectra, but do not provide a means
to identify individual compounds with high specificity or without
extraneous analysis. Unlike molecular networking approaches,
the iSNAP analog function provides results with retention times
and confidence scores for individual scans, and indicates pep-
tide identities without the need for genetic knockouts (Watrous5 Elsevier Ltd All rights reserved
et al., 2012) or direct comparison with known compounds (Yang
et al., 2013) or known producers (Nguyen et al., 2013). In contrast
to molecular networking approaches, iSNAP also does not
merge or discard seemingly identical spectra (Watrous et al.,
2012; Frank et al., 2008), and thus allows for the detection of
distinct isobaric species at different retention times, allowing
users to take full advantage of optimized chromatography. The
iSNAP analog program also does not require manual annotation
of MS/MS data to assign amino acids (Kersten et al., 2011; Me-
dema et al., 2014) or monomer modifications (Watrous et al.,
2012), and has been designed to handle proteinogenic and non-
proteinogenic amino acids, allowing it to function as an informa-
tion-rich and rapid means of detecting families of nonribosomal
peptides. These differences allow the iSNAP analog program to
define important information about specific peptides—as well as
general trends about peptide families—with speed and accuracy
superior to previously published methods. Despite this, there
remain limitations to the iSNAP analog algorithm and MS-based
approaches in general. First, although MS can provide a wealth
of information about the nature and identity of molecules or
monomers units, more comprehensive spectroscopic tech-
niques such as nuclear magnetic resonance (NMR) are still
required to define exact structural features. Second, sensitivity
of LC-MS-based detection is often tied to the ability of a given
molecule to be ionized, meaning that some molecules are
observedmore easily than others. We have conclusively demon-
strated that the iSNAP analog algorithm can map peptide fam-
ilies, but the identification of new analogs is currently limited by
alterations to a single-monomer site, so low-abundance analogs
with multiple independent substitutions remain challenging to
correctly detect and define. In regard to the scoring scheme,
P1 and P2 scores served their purpose as quality indicators for
individual matches, but are not corrected for multiple testing.
The algorithm can be improved if it also reports an estimated
false discovery rate for identification results. In addition, this
approach is currently limited to peptidic natural products, which
possess reliable and predictable potential fragmentation pat-
terns, providing sufficient data for the highly effective analog
detection and elucidation presented here.
In this work, we investigated the tyrocidine family of cyclic
peptides and demonstrated that the iSNAP analog search
algorithm correctly identified all analog compounds for each der-
eplicated tyrocidine. Through an in silico screening approach,
we have shown that our discovery method is highly sensitive in
analog identification and highly accurate in site-specific mono-
mer localization. We have also demonstrated iSNAP’s discovery
potential by identifying more than 125 peptide structures, of
which 70 are novel variants, from a series of cyclic, lipo-, and gly-
copeptides. While the extensive genetic diversity observed in
microbial life offers a glimpse of new, promising leads for natural
product discovery, we have demonstrated here that the chemi-
cal diversity of lone biosynthetic assembly lines can provide
new, improved variations of desired scaffolds that parallel this
boundless potential.
SIGNIFICANCE
In this work, we present the iSNAP analog method as an
effective strategy for the untargeted discovery of new nonri-Chemistry & Biology 22, 1259–126bosomal peptides from crude microbial extracts. This
approach does not require the aid of genomic sequence
information, HRMS systems, or prior knowledge of the sam-
ple for positive analog identifications. iSNAP’s automated
analog processes have been applied to several potent anti-
microbial producers, leading to the discovery of more than
70 novel unreported peptide variants including one with
improved potency, all without the use of bioassay-guided
isolation. HRMS, MSn analysis, and 1D/2D NMR measure-
ments of isolated variants further establishes iSNAP’s
analog capabilities as a true discovery tool.
EXPERIMENTAL PROCEDURES
General
LC-MS/MS data acquisition was obtained on a Bruker Amazon-X ion-trap
mass spectrometer coupled to a Dionex Ultimate 3000 high-performance
liquid chromatography (HPLC) system running under Hystar 3.2 control with
Trap control 7.0 and Chromeleon 6.2. Spectra were generated using electro-
spray ionization and under collision-induced dissociation (N2 nebulizer gas:
25 psi; He dry gas: 7.5 psi; temperature: 250C). Automated MSn acquisitions
were performed from 450 to 1600 m/z for tyrocidines, across a scan range of
100–2,000 m/z using the Enhanced Resolution setting. MS/MS analysis pa-
rameters included isolation width at n = 4, precursor ions at n = 10, threshold
cutoff from 400 to 600,000, active exclusion at n = 4 spectra over 20 s, and
CID fragmentation set to 1.25 V across a voltage sweep of 25%–200%. Bruker
raw data files were converted to .mzXML format using Bruker conversion soft-
ware, CompassXport, prior to iSNAP Analog analysis (http://www.ionsource.
com/functional_reviews/CompassXport/CompassXport.htm). For analytical
flow rates a UV/MS flow splitter of 10:1 was used. LC-MS spectral analysis
was performed using Compass DataAnalysis 4.1 (Bruker). HRMS measure-
ments were performed in positive electrospray ionization using a Bruker maXis
4G UHR-TOF mass spectrometer coupled to a Dionex Ultimate 3000 HPLC
system running Hystar 3.2 control and under standardized LC conditions,
with calibrations done using sodium formate. 1D and 2D NMR measurements
were acquired using a Bruker Avance III 700-MHz NMR spectrometer equip-
ped with a 5-mm QNP cryoprobe, operating at 700.17 MHz for 1H NMR and
176.08 MHz for 13C NMR. Chemical shifts were referenced to the internal sol-
vent peaks: 3.31 ppm (1H) and 49.00 ppm (13C) for CD3CD. Surfactin (S-3523)
and seglitide (S-1316) standards were purchased from Sigma-Aldrich.
Microbial Strains
B. laterosporus and B. parabrevis were obtained from the German Resource
Center for Biological Material (DSMZ, DSM no. 25 and 362, respectively).
P. polymyxa was obtained from the American Type Culture Collection
(ATCC; no. 21,830). Environmental Actinomycete NAM12 was isolated from
an environmental soil sample collection performed at McMaster University.
B. laterosporus, B. parabrevis, and P. polymyxawere maintained on Luria-Ber-
tani agar plates at 30C. NAM12 was maintained on Bennett’s agar plates at
30C.
Cytoscape Depiction of Tyrocidine, Loloatin, LI-F0, and Arylomycin
Chemical Space
Cytoscape plots were assembled using Cytoscape 3.0.1, imported from a
manually curated network file of for each peptide, connected through single
amino acid substitutions. Nodes were automatically distributed by preset
preferred layout and manually adjusted to account for subsequent resizing.
An exported .pdf file wasmanipulated using Adobe Illustrator CS6, resizing no-
des according to their relative abundance, and in the case of the tyrocidines by
relative size.
In Silico Scanning Analysis
Compound structures were modified in ChemBioDraw Ultra 13.0 to substitute
an a glycine, alanine, threonine, histidine, and Br-tryptophan at each of the ten
monomer positions for the tyrocidines, six positions for seglitide, seven for sur-
factin B, and six for WS9326a. The structures were converted to SMILES9, September 17, 2015 ª2015 Elsevier Ltd All rights reserved 1267
codes and compiled into an uploadable text file for analysis. The LC-MS/MS
chromatograms of the tyrocidines, WS9326a, seglitide, and surfactin were
then analyzed by iSNAP analog using each of themonomer-substituted analog
candidates as individual seeds via the uploaded text files. Reports were
analyzed manually to identify whether an analog candidate of the monomer-
substituted structures was matched to the MS/MS scans containing the
appropriate peptide structure.
Additional experimental procedures can be found in the Supplemental
Information.
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